Laboratory findings
| Evaluation time . | Peripheral blood . | BM . | ||||||
|---|---|---|---|---|---|---|---|---|
| Hb (g/L) . | MCV (fL) . | WBC (× 109/L) . | ANC (× 109/L) . | Plts (× 109/L) . | RSs (% of erythroid precursors) . | Dyserythropoiesis/ megaloblastic changes . | Plasma cell iron . | |
| Presentation | 64 | 102 | 1.5 | 2.85 | 192 | 21 | Marked | Yes* |
| Initiation of EPO and G-CSF | 72 | 101 | 1.2 | 3.48 | 171 | ND | ND | ND |
| After 3 wk of EPO and G-CSF | 124 | 98 | 12.4 | 9.92 | 140 | ND | ND | ND |
| After 3 mo of EPO and G-CSF | 69 | 106 | 4.4 | 3.04 | 160 | 19 | Marked | Yes* |
| After copper therapy | 132 | 89 | 9.4 | 6.2 | 232 | None | None | None |
| Evaluation time . | Peripheral blood . | BM . | ||||||
|---|---|---|---|---|---|---|---|---|
| Hb (g/L) . | MCV (fL) . | WBC (× 109/L) . | ANC (× 109/L) . | Plts (× 109/L) . | RSs (% of erythroid precursors) . | Dyserythropoiesis/ megaloblastic changes . | Plasma cell iron . | |
| Presentation | 64 | 102 | 1.5 | 2.85 | 192 | 21 | Marked | Yes* |
| Initiation of EPO and G-CSF | 72 | 101 | 1.2 | 3.48 | 171 | ND | ND | ND |
| After 3 wk of EPO and G-CSF | 124 | 98 | 12.4 | 9.92 | 140 | ND | ND | ND |
| After 3 mo of EPO and G-CSF | 69 | 106 | 4.4 | 3.04 | 160 | 19 | Marked | Yes* |
| After copper therapy | 132 | 89 | 9.4 | 6.2 | 232 | None | None | None |
ANC indicates absolute neutrophil count; Plts, platelets; and ND, not done.
Several plasma cells had iron in the cytoplasm.